PharmEnable
PharmEnable Therapeutics is a biopharmaceutical company focused on reimagining small molecule therapeutics through AI. They aim to develop life-changing medicines for cancer and neurological diseases by targeting previously inaccessible targets within the brain and inside cells. Their proprietary AI-enabled drug discovery platform, chemSEEK, allows them to unlock novel chemical space and achieve the specificity of biologics with small molecule drug design. The company is a spin-out from the University of Cambridge, UK, and boasts a world-class team with expertise in drug discovery, AI, and business development. PharmEnable has established collaborations with companies like Denali Therapeutics and Sosei Heptares, and has secured significant financing, indicating traction in the industry.
PharmEnable
PharmEnable Therapeutics is a biopharmaceutical company focused on reimagining small molecule therapeutics through AI. They aim to develop life-changing medicines for cancer and neurological diseases by targeting previously inaccessible targets within the brain and inside cells. Their proprietary AI-enabled drug discovery platform, chemSEEK, allows them to unlock novel chemical space and achieve the specificity of biologics with small molecule drug design. The company is a spin-out from the University of Cambridge, UK, and boasts a world-class team with expertise in drug discovery, AI, and business development. PharmEnable has established collaborations with companies like Denali Therapeutics and Sosei Heptares, and has secured significant financing, indicating traction in the industry.